Loading clinical trials...
Loading clinical trials...
To evaluate the effect of combined 5-FU and low molecular weight heparin in infusion on the rate of retinal redetachment after silicone oil removal in cases of proliferative vitreoretinopathy (PVR).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shahid Beheshti University of Medical Sciences
NCT06541574 · Proliferative Vitreoretinopathy, Rhegmatogenous Retinal Detachment
NCT05660447 · Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy
NCT07386678 · Retinal Detachment Rhegmatogenous, Proliferative Vitreoretinopathy, and more
NCT04136366 · Proliferative Vitreoretinopathy
NCT06818721 · Retinal Detachment Rhegmatogenous, Proliferative Vitreoretinopathy
Hamid Ahmadieh, MD
Tehran, Tehran Province
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions